scispace - formally typeset
G

George Hauser

Researcher at Harvard University

Publications -  79
Citations -  2474

George Hauser is an academic researcher from Harvard University. The author has contributed to research in topics: Inositol & Phospholipid. The author has an hindex of 32, co-authored 79 publications receiving 2459 citations. Previous affiliations of George Hauser include University of Houston & McLean Hospital.

Papers
More filters
Journal ArticleDOI

Regional distribution of polyphosphoinositides in rat brain.

TL;DR: The regional distribution of the remaining polyphosphoinositides approached that of galactolipids which substantiates earlier conclusions that a large fraction of these compounds is present in myelin and suggests that the labile portion may be predominantly in other structures.
Journal ArticleDOI

Rhamnose and rhamnolipide biosynthesis by Pseudomonas aeruginosa.

TL;DR: Data is presented on the incorporation of radioactivity from glycerol-c&14, glycerl-P-C14, and acetate-l-Cl4 into rhamnolipide and the structure of both constituent moieties are of considerable significance in their own right.
Journal ArticleDOI

The biosynthesis of free and phosphatide myo-inositol from glucose by mammalian tissue slices.

TL;DR: This communication provides evidence for the ability of slices of brain, liver, and kidney to convert labeled glucose to inositol, isolated from both the lipid and water extracts of the tissues.
Journal ArticleDOI

Studies on the production of glycolipide by Pseudomonas aeruginosa.

TL;DR: The strain of P. aeruginosa as follows: used in these experiments was obtained from the extract from the Pseudomonas strain this article, which is composed of two moles each of MATERIS AND THODS L-rhamnose and 1-hydroxydecanoic acid linked Bacterial strain.
Journal ArticleDOI

Identification of cytidine diphosphate-diglyceride in the pineal gland of the rat and its accumulation in the presence of DL-propranolol.

TL;DR: Since CDP-diglyceride did not accumulate in the absence of the drug, its availability may normally be the limiting factor in phosphatidylinositol and phosph atidylglycerol biosynthesis, and when propranol is present, inositol may become limiting and thus may lead to the observed labeling pattern.